Guimbard-Pérez JH, Nicolás-Ortiz P, Cristiani-Winer M, Orosco-Falcone D, Gutiérrez N, Pomba M

Language: Spanish
References: 20
Page: 276-281
PDF size: 394.21 Kb.

ABSTRACT

Introduction: In vitro studies suggest that vancomycin is highly cytotoxic for osteoblasts. However, several clinical studies in vivo have not provided evidence or determined that effect on osteogenesis. The aim of this work was to investigate the effect of topical vancomycin on a lumbar arthrodesis model on New Zealand white rabbits. Material and methods: Double-blind randomized experimental study. Posterolateral spinal fusion was performed on 30 rabbits, divided into two groups, A: graft/placebo, B: graft/vancomycin. After sacrificing them, the bone callus was evaluated with axial tomography and classified into three groups: no fusion (0), partial/incomplete fusion (1) and fusion (2). The samples were also histologically analyzed. The associations between the presence of fusion (complete/incomplete) and the group tested were estimated using Poisson log-linear models with two covariates. Adherences to histologically obtained responses were studied using contingency tables and χ² tests. The significance level was set equal to 0.05. Results: Treatment with vancomycin has 30% (0.30. CI 95%: 0.12-0.94) less chance compared to the placebo group, of presenting complete fusion. In other words, the vancomycin group has 2.3 times (CI 95%: 1.02-4.91) more likelyhood, compared to placebo, to have incomplete fusion. Conclusion: The application of vancomycin powder mixed with graft reduces fusion rates by 30%, but at doses 5 times higher than those routinely used in arthrodesis by the authors’ medical team.

REFERENCES

1. Eder C, Schenk S, Trifinopoulos J, Külekci B, Kienzl M, Schildböck S, et al. Does intrawound application of vancomycin influence bone healing in spinal surgery? Eur Spine J. 2016; 25(4): 1021-8.

2. Philp AM, Raja S, Philp A, Newton Ede MP, Jones SW. The effect of vancomycin and gentamicin antibiotics on human osteoblast proliferation, metabolic function, and bone mineralization. Spine (Phila Pa 1976). 2017; 42(3): 202-7.

3. Savage JW, Anderson PA. An update on modifiable factors to reduce the risk of surgical site infections. Spine J. 2013; 13(9): 1017-29.

4. Godil SS, Parker SL, O’Neill KR, Devin CJ, McGirt MJ. Comparative effectiveness and cost-benefit analysis of local application of vancomycin powder in posterior spinal fusion for spine trauma: clinical article. J Neurosurg Spine. 2013; 19(3): 331-5.

5. Armaghani SJ, Menge TJ, Lovejoy SA, Mencio GA, Martus JE. Safety of topical vancomycin for pediatric spinal deformity: nontoxic serum levels with supratherapeutic drain levels. Spine (Phila Pa 1976). 2014; 39(20): 1683-7.

6. Chiang HY, Herwaldt LA, Blevins AE, Cho E, Schweizer ML. Effectiveness of local vancomycin powder to decrease surgical site infections: a meta-analysis. Spine J. 2014; 14(3): 397-407.

7. O’Neill KR, Smith JG, Abtahi AM, Archer KR, Spengler DM, McGirt MJ, et al. Reduced surgical site infections in patients undergoing posterior spinal stabilization of traumatic injuries using vancomycin powder. Spine J. 2011; 11(7): 641-6.

8. Molinari RW, Khera OA, Molinari WJ 3rd. Prophylactic intraoperative powdered vancomycin and postoperative deep spinal wound infection: 1,512 consecutive surgical cases over a 6-year period. Eur Spine J. 2012; 21 Suppl 4(Suppl 4): S476-82.

9. Caroom C, Tullar JM, Benton EG Jr, Jones JR, Chaput CD. Intrawound vancomycin powder reduces surgical site infections in posterior cervical fusion. Spine (Phila Pa 1976). 2013; 38(14): 1183-7.

10. Rathbone CR, Cross JD, Brown KV, Murray CK, Wenke JC. Effect of various concentrations of antibiotics on osteogenic cell viability and activity. J Orthop Res. 2011; 29(7): 1070-4.

11. Mendoza MC, Sonn KA, Kannan AS, Bellary SS, Mitchell SM, Singh G, et al. The effect of vancomycin powder on bone healing in a rat spinal rhBMP-2 model. J Neurosurg Spine. 2016; 25(2): 147-53.

12. Newton Ede MP, Philp AM, Philp A, Richardson SM, Mohammad S, Jones SW. Povidone-iodine has a profound effect on in vitro osteoblast proliferation and metabolic function and inhibits their ability to mineralize and form bone. Spine (Phila Pa 1976). 2016; 41(9): 729-34.

13. Goldschmidt E, Rasmussen J, Chabot JD, Gandhoke G, Luzzi E, Merlotti L, et al. The effect of vancomycin powder on human dural fibroblast culture and its implications for dural repair during spine surgery. J Neurosurg Spine. 2016; 25(5): 665-70.

14. Sweet FA, Roh M, Sliva C. Intrawound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions: efficacy, drug levels, and patient outcomes. Spine (Phila Pa 1976). 2011; 36(24): 2084-8.

15. Kang DG, Holekamp TF, Wagner SC, Lehman RA Jr. Intrasite vancomycin powder for the prevention of surgical site infection in spine surgery: a systematic literature review. Spine J. 2015; 15(4): 762-70.

16. Edin ML, Miclau T, Lester GE, Lindsey RW, Dahners LE. Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthop Relat Res. 1996; (333): 245-51.

17. Ketonis C, Barr S, Adams CS, Shapiro IM, Parvizi J, Hickok NJ. Vancomycin bonded to bone grafts prevents bacterial colonization. Antimicrob Agents Chemother. 2011; 55(2): 487-94.

18. Alcalá-Cerra G, Paternina-Caicedo AJ, Moscote-Salazar LR, Gutiérrez-Paternina JJ, Niño-Hernández LM. Application of vancomycin powder into the wound during spine surgery: systematic review and meta-analysis. Rev Esp Cir Ortop Traumatol. 2014; 58(3): 182-91.

19. Lee GH, Hwang JD, Choi JY, Park HJ, Cho JY, Kim KW, et al. An acidic pH environment increases cell death and pro-inflammatory cytokine release in osteoblasts: the involvement of BAX inhibitor-1. Int J Biochem Cell Biol. 2011; 43(9): 1305-17.

20. Zhang Y, Shen L, Mao Z, Wang N, Wang X, Huang X, et al. Icariin enhances bone repair in rabbits with bone infection during post-infection treatment and prevents inhibition of osteoblasts by vancomycin. Front Pharmacol. 2017; 8: 784.